Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Topotecan in Second-Line Small Cell Lung Cancer
NCT00193388Phase 2Completed
- Sponsor
- SCRI Development Innovations
- Start
- Sep 2002
- Primary completion
- Dec 2004
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of topotecan in small cell lung cancer (SCLC), sponsored by SCRI Development Innovations. Started Sep 2002; status: completed.
02
Drugs
topotecan
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00193388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00193388.